Table 3.
HR of incident PAD by eGFR, Visit 2
eGFR ≥60 |
eGFR <60 |
P-for-interaction | |||
---|---|---|---|---|---|
N
|
11 606 |
233 |
|||
Events |
436 |
35 |
|||
Variable | HR (95% CI) | P-value | HR (95% CI) | P-value | |
Higher calciuma | 1.06 (0.86–1.29) | 0.60 | 0.68 (0.31–1.48) | 0.33 | 0.17 |
Higher phosphorusa | 1.01 (0.83–1.24) | 0.90 | 1.22 (0.53–2.78) | 0.64 | 0.95 |
Higher iPTHa | 1.07 (0.88–1.30) | 0.52 | 0.51 (0.22–1.22) | 0.13 | 0.93 |
Higher FGF-23a | 1.09 (0.90–1.32) | 0.39 | 1.40 (0.42–4.73) | 0.58 | 0.84 |
Higher calciumb | 0.59 (0.33–1.07) | 0.08 | 2.10 (0.44–9.97) | 0.35 | 0.43 |
Higher phosphorusb | 2.01 (1.36–2.95) | <0.001 | 1.87 (0.64–5.49) | 0.25 | 0.82 |
Higher iPTHb | 1.09 (0.76–1.55) | 0.64 | 2.24 (0.94–5.36) | 0.07 | 0.01 |
Higher FGF-23b | 1.43 (1.10–1.86) | 0.01 | 0.94 (0.37–2.39) | 0.90 | 0.60 |
Adjusted for age, sex, race, education, smoking status, drinking status, hypertension, diabetes mellitus, prevalent coronary heart disease, total cholesterol and HDL cholesterol.
Calcium, phosphorus, iPTH and FGF-23 above versus below their median values.
Calcium, phosphorus, iPTH and FGF-23, above versus below clinical cut-points.